MIRM
NASDAQ · Biotechnology
Mirum Pharmaceuticals Inc
$94.01
-2.96 (-3.05%)
Performance
1D
—
1W
+10.60%
1M
+16.58%
3M
-4.75%
6M
-11.45%
1Y
+38.82%
YTD
+20.42%
Open$96.36
Previous Close$96.97
Day High$98.98
Day Low$93.84
52W High$130.00
52W Low$63.23
Volume—
Avg Volume549.0K
Market Cap5.48B
P/E Ratio—
EPS$-14.55
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$89.51
Above
SMA 200
$98.54
Below
RSI (14)
73.4
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-29.0% upside
Current
$94.01
$94.01
Target
$66.73
$66.73
$36.90
$66.73 avg
$76.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 669.09M | 353.77M | 354.29M |
| Net Income | -29,984,803 | -14,268,663 | 95.30M |
| Profit Margin | -4.5% | -4.3% | 26.9% |
| EBITDA | 2.71M | 1.36M | 155.69M |
| Free Cash Flow | — | — | 58.63M |
| Rev Growth | +89.1% | +89.1% | +17.5% |
| Debt/Equity | 0.98 | 0.98 | 0.71 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |